AIM: Reduced heart rate variability (HRV) is a manifestation of cardiac autonomic neuropathy, a known complication of type 1 diabetes (T1D). We evaluated whether HRV predicted coronary artery calcium (CAC) progression. METHODS: Subjects between 19 and 56 years of age with T1D or those without diabetes from the Coronary Artery Calcification in Type 1 Diabetes study underwent supine deep breathing 12-lead electrocardiograms. The SD of consecutive RR intervals was used as a measure of HRV. CAC was measured at two visits 6.0 ± 0.5 years apart. Progression of CAC was defined as an increase in square root transformed CAC volume of ≥ 2.5 mm(3), excluding patients who had cardiovascular events during follow-up. RESULTS: Reduced HRV was associated with older age, higher hemoglobin A1c, elevated albuminuria, CAC volume at baseline, and increased fibrinogen. Higher HRV at baseline was associated with lower likelihood CAC progression (odds ratio = 0.71, 95% confidence interval 0.56-0.90, P = 0.005), and the adjustment for known cardiovascular risk factors did not change this strong association, including adjustment for inflammatory markers. CONCLUSIONS: Reduced HRV predicted progression of CAC in adults with and without T1D. This association further supports the participation of autonomic neuropathy in the atherosclerosis process.
AIM: Reduced heart rate variability (HRV) is a manifestation of cardiac autonomic neuropathy, a known complication of type 1 diabetes (T1D). We evaluated whether HRV predicted coronary artery calcium (CAC) progression. METHODS: Subjects between 19 and 56 years of age with T1D or those without diabetes from the Coronary Artery Calcification in Type 1 Diabetes study underwent supine deep breathing 12-lead electrocardiograms. The SD of consecutive RR intervals was used as a measure of HRV. CAC was measured at two visits 6.0 ± 0.5 years apart. Progression of CAC was defined as an increase in square root transformed CAC volume of ≥ 2.5 mm(3), excluding patients who had cardiovascular events during follow-up. RESULTS: Reduced HRV was associated with older age, higher hemoglobin A1c, elevated albuminuria, CAC volume at baseline, and increased fibrinogen. Higher HRV at baseline was associated with lower likelihood CAC progression (odds ratio = 0.71, 95% confidence interval 0.56-0.90, P = 0.005), and the adjustment for known cardiovascular risk factors did not change this strong association, including adjustment for inflammatory markers. CONCLUSIONS: Reduced HRV predicted progression of CAC in adults with and without T1D. This association further supports the participation of autonomic neuropathy in the atherosclerosis process.
Authors: John E Hokanson; Todd MacKenzie; Gregory Kinney; Janet K Snell-Bergeon; Dana Dabelea; James Ehrlich; Robert H Eckel; Marian Rewers Journal: AJR Am J Roentgenol Date: 2004-05 Impact factor: 3.959
Authors: M V Pitzalis; F Mastropasqua; F Massari; C Forleo; M Di Maggio; A Passantino; R Colombo; M Di Biase; P Rizzon Journal: Cardiovasc Res Date: 1996-08 Impact factor: 10.787
Authors: Elizabeth J Mezick; Karen A Matthews; Martica H Hall; J Richard Jennings; Thomas W Kamarck Journal: Psychophysiology Date: 2013-09-09 Impact factor: 4.016
Authors: Lara E Sucheston-Campbell; Alyssa I Clay-Gilmour; William E Barlow; G Thomas Budd; Daniel O Stram; Christopher A Haiman; Xin Sheng; Li Yan; Gary Zirpoli; Song Yao; Chen Jiang; Kouros Owzar; Dawn Hershman; Kathy S Albain; Daniel F Hayes; Halle C Moore; Timothy J Hobday; James A Stewart; Abbas Rizvi; Claudine Isaacs; Muhammad Salim; Jule R Gralow; Gabriel N Hortobagyi; Robert B Livingston; Deanna L Kroetz; Christine B Ambrosone Journal: Pharmacogenet Genomics Date: 2018-02 Impact factor: 2.089
Authors: Mamta Jaiswal; Elaine M Urbina; R Paul Wadwa; Jennifer W Talton; Ralph B D'Agostino; Richard F Hamman; Tasha E Fingerlin; Stephen R Daniels; Santica M Marcovina; Lawrence M Dolan; Dana Dabelea Journal: Diabetes Care Date: 2013-02-22 Impact factor: 19.112
Authors: Priscila S Guimaraes; Domitila A Huber; Maria J Campagnole-Santos; Ann M Schreihofer Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-02-26 Impact factor: 3.619
Authors: Stefanie T LoSavio; Jean C Beckham; Stephanie Y Wells; Patricia A Resick; Andrew Sherwood; Cynthia J Coffman; Angela C Kirby; Tiffany A Beaver; Michelle F Dennis; Lana L Watkins Journal: Contemp Clin Trials Date: 2021-01-08 Impact factor: 2.226